Genetic Diagnostics & Student CEOs with Dr. Jonathon Hill
Summary In this conversation, Dr. Jonathon Hill discusses the unique partnership between his lab and the university, which allows students to become entrepreneurs, develop their own projects, and beco...
4 Elo 202433min
How AI is Helping Diagnose Disease with Chuck Piccirillo
Summary In this conversation, Gregory Austin and Chad Briscoe interview Chuck Piccirillo, CEO of Zealic Health, about his experience in the healthcare industry and the focus on patient-centric soluti...
2 Elo 202438min
Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick
Summary Dr. Andy Vick shares some of the things that surprised him throughout his career and he discusses his passion for reptiles and his experience discussing the pharmaceutical potential of venom w...
15 Heinä 202438min
Amyloidosis Exposed: New Hope with Dr. Vick
Summary Dr. Andy Vick discusses his work at Attralus Therapeutics, a biotech company focused on developing treatments for systemic amyloidosis. He explains the etiology of the disease and how Attralus...
1 Heinä 202440min
A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill
A Diagnostic Breakthrough for Alzheimer’s Summary In this conversation, Dr. Jonathan Hill discusses his work in nanopore sequencing-based technology and its applications in genetic and epigenetic rese...
1 Kesä 202430min
The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke
The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke Summary In Episode 13, Jason Burke discusses the unique approach of the Duke program in providing real-world healthcare data...
15 Touko 202435min
Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke
Summary In this episode of BioTalk Unzipped, the hosts discuss the applications and ethical concerns surrounding organoids, which are 3D cell clusters that mimic the features of full-sized organs. The...
1 Touko 202434min
Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner
Summary In this episode, Scott Schliebner discusses the unique challenges and complexities of rare disease trials. He highlights the difficulties in recruiting patients, the multidisciplinary nature o...
15 Huhti 202436min
